Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7879 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7687 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.748 |
Intermediate Similarity |
NPD8836 |
Approved |
0.741 |
Intermediate Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD548 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD8833 |
Approved |
0.7252 |
Intermediate Similarity |
NPD8831 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1058 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD3708 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD9084 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD3696 |
Approved |
0.7034 |
Intermediate Similarity |
NPD3695 |
Approved |
0.7034 |
Intermediate Similarity |
NPD193 |
Suspended |
0.7025 |
Intermediate Similarity |
NPD1777 |
Approved |
0.7025 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7 |
Intermediate Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD250 |
Approved |
0.6959 |
Remote Similarity |
NPD249 |
Approved |
0.6959 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6939 |
Remote Similarity |
NPD185 |
Approved |
0.6928 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6903 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD4240 |
Approved |
0.6867 |
Remote Similarity |
NPD186 |
Discovery |
0.6867 |
Remote Similarity |
NPD195 |
Approved |
0.6846 |
Remote Similarity |
NPD166 |
Approved |
0.6846 |
Remote Similarity |
NPD171 |
Discontinued |
0.6795 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6779 |
Remote Similarity |
NPD9704 |
Approved |
0.6716 |
Remote Similarity |
NPD757 |
Phase 3 |
0.671 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6689 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6688 |
Remote Similarity |
NPD283 |
Approved |
0.6603 |
Remote Similarity |
NPD242 |
Approved |
0.6603 |
Remote Similarity |
NPD338 |
Approved |
0.6561 |
Remote Similarity |
NPD339 |
Approved |
0.6554 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6519 |
Remote Similarity |
NPD169 |
Phase 2 |
0.6488 |
Remote Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD2630 |
Approved |
0.6437 |
Remote Similarity |
NPD2632 |
Approved |
0.6408 |
Remote Similarity |
NPD78 |
Approved |
0.6408 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.6408 |
Remote Similarity |
NPD9544 |
Approved |
0.6392 |
Remote Similarity |
NPD214 |
Approved |
0.6392 |
Remote Similarity |
NPD213 |
Clinical (unspecified phase) |
0.6383 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6375 |
Remote Similarity |
NPD218 |
Approved |
0.6375 |
Remote Similarity |
NPD217 |
Approved |
0.6375 |
Remote Similarity |
NPD220 |
Clinical (unspecified phase) |
0.6375 |
Remote Similarity |
NPD219 |
Phase 3 |
0.6375 |
Remote Similarity |
NPD216 |
Approved |
0.6375 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6336 |
Remote Similarity |
NPD341 |
Approved |
0.6336 |
Remote Similarity |
NPD340 |
Approved |
0.6331 |
Remote Similarity |
NPD578 |
Discontinued |
0.6331 |
Remote Similarity |
NPD9360 |
Approved |
0.6303 |
Remote Similarity |
NPD7988 |
Suspended |
0.6286 |
Remote Similarity |
NPD580 |
Discontinued |
0.6276 |
Remote Similarity |
NPD1127 |
Approved |
0.6276 |
Remote Similarity |
NPD1128 |
Approved |
0.6258 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD281 |
Approved |
0.6241 |
Remote Similarity |
NPD9409 |
Discontinued |
0.6229 |
Remote Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.622 |
Remote Similarity |
NPD8838 |
Approved |
0.6204 |
Remote Similarity |
NPD9358 |
Approved |
0.6204 |
Remote Similarity |
NPD9373 |
Approved |
0.6204 |
Remote Similarity |
NPD9359 |
Approved |
0.6197 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.617 |
Remote Similarity |
NPD9289 |
Approved |
0.617 |
Remote Similarity |
NPD9292 |
Approved |
0.617 |
Remote Similarity |
NPD307 |
Approved |
0.617 |
Remote Similarity |
NPD76 |
Approved |
0.617 |
Remote Similarity |
NPD9288 |
Approved |
0.6168 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6165 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6149 |
Remote Similarity |
NPD282 |
Approved |
0.6136 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.6121 |
Remote Similarity |
NPD3083 |
Approved |
0.6115 |
Remote Similarity |
NPD9374 |
Approved |
0.6108 |
Remote Similarity |
NPD247 |
Clinical (unspecified phase) |
0.6099 |
Remote Similarity |
NPD9606 |
Approved |
0.6096 |
Remote Similarity |
NPD9696 |
Approved |
0.6082 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.6067 |
Remote Similarity |
NPD207 |
Discontinued |
0.6056 |
Remote Similarity |
NPD9607 |
Approved |
0.6024 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6014 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6013 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD9291 |
Approved |
0.5986 |
Remote Similarity |
NPD1775 |
Approved |
0.5986 |
Remote Similarity |
NPD1085 |
Approved |
0.597 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.5962 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5954 |
Remote Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.5948 |
Remote Similarity |
NPD6112 |
Approved |
0.5932 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5932 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5931 |
Remote Similarity |
NPD306 |
Approved |
0.5931 |
Remote Similarity |
NPD4262 |
Discontinued |
0.5921 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.5909 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.5893 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.5882 |
Remote Similarity |
NPD1121 |
Approved |
0.5882 |
Remote Similarity |
NPD1120 |
Approved |
0.5855 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.5855 |
Remote Similarity |
NPD1264 |
Phase 2 |
0.5852 |
Remote Similarity |
NPD4716 |
Approved |
0.5843 |
Remote Similarity |
NPD1692 |
Approved |
0.5839 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.5827 |
Remote Similarity |
NPD8954 |
Approved |
0.5827 |
Remote Similarity |
NPD8955 |
Approved |
0.5819 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.5804 |
Remote Similarity |
NPD1368 |
Approved |
0.58 |
Remote Similarity |
NPD9571 |
Approved |
0.5796 |
Remote Similarity |
NPD2253 |
Discontinued |
0.5789 |
Remote Similarity |
NPD9193 |
Approved |
0.5789 |
Remote Similarity |
NPD9194 |
Approved |
0.5779 |
Remote Similarity |
NPD535 |
Approved |
0.5778 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.5778 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.5778 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.5775 |
Remote Similarity |
NPD9086 |
Approved |
0.5772 |
Remote Similarity |
NPD9366 |
Approved |
0.5772 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5764 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5732 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5731 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.5722 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.5706 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.5706 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.5696 |
Remote Similarity |
NPD1430 |
Approved |
0.5696 |
Remote Similarity |
NPD1431 |
Approved |
0.5686 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5686 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5677 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.5676 |
Remote Similarity |
NPD798 |
Discontinued |
0.5664 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.5659 |
Remote Similarity |
NPD8565 |
Clinical (unspecified phase) |
0.5658 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.5641 |
Remote Similarity |
NPD9551 |
Approved |
0.5641 |
Remote Similarity |
NPD9550 |
Approved |
0.5633 |
Remote Similarity |
NPD549 |
Approved |
0.5629 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.5629 |
Remote Similarity |
NPD8832 |
Approved |
0.5625 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.5614 |
Remote Similarity |
NPD4143 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD8827 |
Approved |
0.5607 |
Remote Similarity |
NPD1215 |
Discontinued |
0.56
|
Remote Similarity |
NPD4812 |
Phase 1 |